Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Nuclear Cardiology

• Publication date

  2017-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s12350-016-0502-7PMID 27277502PMCID PMC5841447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis

  2016cited by this paper
• Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in 18F-FDG PET Imaging

  2016cited by this paper
• Comparison of myocardial F-18 FDG uptake between overnight and non-overnight fasting in non-diabetic healthy subjects

  2015cited by this paper
• The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis

  2015cited by this paper
• Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD

  2015cited by this paper
• Positron Emission Tomography-Computed Tomography for Imaging of Inflammatory Cardiovascular Diseases : Sarcoidosis, Large-Vessel Arteritis, and Atherosclerosis

  2014cited by this paper
• A Randomized Trial on the Optimization of 18F-FDG Myocardial Uptake Suppression: Implications for Vulnerable Coronary Plaque Imaging

  2014influential reference
• Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.

  2014cited by this paper
• Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis

  2014cited by this paper
• Effect of duration of fasting and diet on the myocardial uptake of F-18-2-fluoro-2-deoxyglucose (F-18 FDG) at rest

  2014cited by this paper
• Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis

  2013cited by this paper
• SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0*

  2013cited by this paper
• Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.

  2013cited by this paper
• Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study.

  2013cited by this paper
• Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.

  2013influential reference
• Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

  2012cited by this paper
• Suppression of myocardial 18F-FDG uptake with a preparatory “Atkins-style” low-carbohydrate diet

  2012cited by this paper
• Suppression of 18F-FDG Myocardial Uptake Using a Fat-Allowed, Carbohydrate-Restricted Diet

  2011cited by this paper
• Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection

  2011cited by this paper
• Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake

  2011cited by this paper
• Detection of Myocardial Damage in Patients With Sarcoidosis

  2009cited by this paper
• Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation

  2009influential reference
• Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial

  2009influential reference
• The Work‐Up and Management of Patients with Apparent or Subclinical Cardiac Sarcoidosis: With Emphasis on the Associated Heart Rhythm Abnormalities

  2009cited by this paper
• Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols

  2005cited by this paper
• Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction.

  2002cited by this paper
• FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.

  2001cited by this paper
• Glucose for the heart.

  1999cited by this paper
• High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.

  1995cited by this paper
• Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

  1992cited by this paper
• Current concepts in cardiovascular physiology

  1990cited by this paper
• Influence of free fatty acids on myocardial oxygen consumption and ischemic injury.

  1981cited by this paper
• A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects.

  1979cited by this paper
• Oral protoveratrine in the treatment of hypertension.

  1958cited by this paper

• 18F-fluorodeoxyglucose PET computed tomography in cardiac sarcoidosis: lessons from a 10-year review.

  2026cites this paper
• Optimizing PET/CT protocols: is 60-minute [18 F]F-FDG uptake sufficient for cardiac sarcoidosis?

  2026influential citation
• Cardiac Sarcoidosis: Pathophysiology and Diagnostic–Therapeutic Processes

  2026cites this paper
• Cardiac PET Imaging for Coronary Artery Disease and Heart Failure: An Overview.

  2025cites this paper
• Evidenzbasierte Einsatzmöglichkeiten der FDG-PET in der kardialen Entzündungsdiagnostik

  2025influential citation
• Improving Infective Endocarditis Diagnosis by Combining Semi-Quantitative and Visual Findings Obtained from Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging.

  2025cites this paper
• Infective endocarditis involving all native heart valves diagnosed by 18F-FDG PET.

  2025cites this paper
• Molecular imaging of cardiovascular disease: Current status and future perspective.

  2025cites this paper
• Direct Comparison of 67Ga-Scintigraphy and Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Cardiac Sarcoidosis

  2025cites this paper
• Role of multimodality imaging in cardiac implantable electronic devices related infection and infective endocarditis

  2025influential citation
• The Role of FDG PET/CT in Assessing Cardiac Sarcoidosis with No High-Risk Cardiac Features and Normal CMR.

  2025cites this paper
• CARDIAC TUMORS: UPDATED CLASSIFICATIONS AND MAIN CLINICO-PATHOLOGIC FINDINGS.

  2025cites this paper
• Radionuclide Imaging of Infective Endocarditis.

  2025cites this paper
• Diagnoses and outcomes of patients referred for FDG PET/CT for suspected cardiac sarcoidosis.

  2025cites this paper
• Radiomics as a new frontier in modern rheumatology: Chest pathology visualization advances and prospects

  2025cites this paper
• Somatostatin receptor imaging with Ga-68 DOTANOC PET/CT in the response assessment of cardiac sarcoidosis

  2025cites this paper
• Top 7 Diagnostic Dilemmas in Cardiac Sarcoidosis: Lessons from Clinical Practice

  2025cites this paper
• Prolonged fasting for optimizing myocardial fluorodeoxyglucose suppression.

  2025cites this paper
• Assessment of Cardiac Sarcoidosis with PET/CT

  2025cites this paper
• Clinical Cases in the Diagnosis of Cardiac Sarcoidosis

  2025cites this paper
• Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging

  2024cites this paper
• EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0

  2024cites this paper
• Extrapulmonary sarcoidosis.

  2024cites this paper
• An assessment of PET and CMR radiomic features for the detection of cardiac sarcoidosis

  2024cites this paper
• Place de la médecine nucléaire dans l’exploration des cardiomyopathies inflammatoires : un atout diagnostique et pronostique

  2024cites this paper
• Novel tracers to assess myocardial inflammation with radionuclide imaging.

  2024cites this paper
• 18F-FDG PET/CT in Inflammation and Infection: Procedural Guideline by the Korean Society of Nuclear Medicine

  2024cites this paper
• Management of cardiac sarcoidosis.

  2024cites this paper
• Diagnostic Utility of SGLT2 Inhibitors to Facilitate Myocardial Glucose Suppression During Evaluation of Myocardial Inflammation.

  2024cites this paper
• The Role of Multimodality Imaging in Cardiomyopathy

  2024cites this paper
• Contemporary Role of Positron Emission Tomography (PET) in Endocarditis: A Narrative Review

  2024cites this paper
• Recurrence of an undifferentiated pleomorphic pulmonary artery sarcoma 8 years after initial presentation: a case report

  2024cites this paper
• Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT: Identification and Prognostic Significance

  2024cites this paper
• 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee.

  2024cites this paper
• Standardized ketogenic dietary preparation for metabolic PET imaging in suspected and known cardiac sarcoidosis

  2024cites this paper
• Sarcoidose Cardíaca: O Camaleão da Cardiologia

  2024cites this paper
• Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association

  2024cites this paper
• How to Prepare a Patient for FDG PET Imaging to Assess Myocardial Inflammation.

  2024cites this paper
• Cardiac Sarcoidosis: The Chameleon of Cardiology

  2024cites this paper
• The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppression

  2024cites this paper
• Multimodality Imaging of Cardiac Myxomas

  2024cites this paper
• Blood Sugar and Ketosis in PET-FDG Sarcoid Imaging: Finding the Sweet Spot.

  2024cites this paper
• Automation is crucial for precision medicine.

  2024cites this paper
• Imaging of Cardiac Sarcoidosis: An Update and Future Aspects.

  2024cites this paper
• Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging.

  2023cites this paper
• Multimodality imaging assessment of primary pericardial rhabdomyosarcoma: a case report

  2023cites this paper
• Exploring the Utility of Cardiovascular Magnetic Resonance Radiomic Feature Extraction for Evaluation of Cardiac Sarcoidosis

  2023cites this paper
• Association of longitudinal cardiac troponin trajectory with adverse events in patients with cardiac sarcoidosis.

  2023cites this paper
• Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation: PRESTIGE Study.

  2023cites this paper
• Tales from the future—nuclear cardio-oncology, from prediction to diagnosis and monitoring

  2023cites this paper
• Pancreatic involvement in Erdheim-Chester disease: Rare presentation of a rare disease

  2023cites this paper
• Radionuclide Imaging of Infective Endocarditis.

  2023cites this paper
• Diagnostic Approach and Management of Cardiac Sarcoidosis

  2023cites this paper
• Cardiac sarcoidosis: the role of cardiac MRI and 18F-FDG-PET/CT in the diagnosis and treatment follow-up.

  2023cites this paper
• Imaging of Endocarditis and Cardiac Device-Related Infections: An Update.

  2023cites this paper
• Sarcoid heart disease and imaging

  2023cites this paper
• Cardiac sarcoidosis

  2023cites this paper
• Role of Imaging in Cardiomyopathies

  2023cites this paper
• Bilateral Carotid Artery Molecular Calcification Assessed by [18F] Fluoride PET/CT: Correlation with Cardiovascular and Thromboembolic Risk Factors

  2023cites this paper
• A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression on ^18F-FDG PET imaging

  2023influential citation
• Turning the heart off: give it a second try?

  2022influential citation
• Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM

  2022cites this paper
• Nuclear medicine imaging methods of radiation-induced cardiotoxicity.

  2022cites this paper
• Exploring the Utility of Radiomic Feature Extraction to Improve the Diagnostic Accuracy of Cardiac Sarcoidosis Using FDG PET

  2022cites this paper
• Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET.

  2022cites this paper
• Value of rest ^18F-FDG myocardial imaging in the diagnosis of obstructive coronary artery disease in Chinese patients with suspected unstable angina: A prospective real-world clinical study

  2022cites this paper
• Utilization of cardiac imaging in sarcoidosis

  2022cites this paper
• A 65-Year-Old Male With Classic Cardiac Sarcoidosis: Case Report and Review of the Literature

  2022cites this paper
• Imaging in Cardiac Sarcoidosis: Complementary Role of Cardiac Magnetic Resonance and Cardiac Positron Emission Tomography

  2022cites this paper
• Case report: Disseminated Scedosporium apiospermum infection with invasive right atrial mass in a heart transplant patient

  2022cites this paper
• Metabolomic Signatures of Myocardial Glucose Uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography

  2022cites this paper
• The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies

  2022cites this paper
• Recent advances in PET-MRI for cardiac sarcoidosis

  2022cites this paper
• Multimodality Imaging of Benign Primary Cardiac Tumor

  2022cites this paper
• Cardiac PET/MR

  2022cites this paper
• Transcriptional and Immune Landscape of Cardiac Sarcoidosis

  2022cites this paper
• FDG PET/CT Imaging of Sarcoidosis.

  2022cites this paper
• Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art review

  2022cites this paper
• Potential clinical utility of 68Ga-DOTATATE PET/CT for detection and response assessment in cardiac sarcoidosis

  2022cites this paper
• Role of serial cardiac 18F-FDG PET-MRI in Anderson–Fabry disease: a pilot study

  2021influential citation
• Multimodality Imaging in Cardio-Oncology

  2021cites this paper
• APPLICATIONS OF PET-MRI IN CARDIOVASCULAR DISORDERS

  2021cites this paper
• PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).

  2021cites this paper
• Aortitis and coronary artery vasculitis of unusual etiology: IgG4-related disease defined by ^18F-fluorodeoxyglucose positron emission tomography (FDG-PET)

  2021cites this paper
• Nuclear Imaging in Infective Endocarditis

  2021cites this paper
• An Intravenous 100-mL Lipid Emulsion Infusion Dramatically Improves Myocardial Glucose Metabolism Extinction in Cardiac FDG PET Clinical Practice

  2021cites this paper
• The clinical utility of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in guiding myocardial revascularisation

  2021cites this paper
• Non-18F-FDG/18F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature.

  2021cites this paper
• Associations of physiologic myocardial 18F-FDG uptake with fasting duration, HbA1c, and regular exercise

  2021cites this paper
• Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.

  2021cites this paper
• Cardiac sarcoidosis: state-of-the-art review

  2021cites this paper
• PET/CT Imaging: Patient Instructions and Preparation

  2021cites this paper
• Diagnosis of cardiac sarcoidosis: a primer for non-imagers

  2021cites this paper
• PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers

  2021influential citation
• Molecular Imaging of Vulnerable Plaque

  2021cites this paper
• Best Practices for Imaging Cardiac Device-Related Infections and Endocarditis: A JACC: Cardiovascular Imaging Expert Panel Statement.

  2021cites this paper
• State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation

  2021cites this paper
• Infective Endocarditis and Cardiovascular Implantable Electronic Device Infection

  2021cites this paper
• Stable Extent of Recurrently Active Cardiac and Cutaneous Sarcoidosis

  2021cites this paper
• Normal Variants and Pitfalls in Cardiac PET/CT.

  2021cites this paper